Paragraph IV certification under the Hatch-Waxman Act allows generic drug makers to challenge brand-name patents and enter the market faster. Learn how this legal tool drives down drug prices and what makes it unique to the U.S.
Health Information (127)
Health & Nutrition (9)
Health & Wellness (3)
Science & Technology (2)
Health (1)
February 2026 (2)
January 2026 (25)
December 2025 (30)
November 2025 (20)
October 2025 (28)
September 2025 (15)
August 2025 (6)
July 2025 (21)